Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/01/13 16:19:38」(JST)
wiki en
English Journal
- Monoclonal antibodies in gynecological cancer: a critical point of view.
- Bellati F, Napoletano C, Gasparri ML, Visconti V, Zizzari IG, Ruscito I, Caccetta J, Rughetti A, Benedetti-Panici P, Nuti M.SourceDepartment of Gynecology and Obstetrics, Sapienza University of Rome, Italy.
- Clinical & developmental immunology.Clin Dev Immunol.2011;2011:890758. Epub 2011 Dec 26.
- During the last decades, several improvements in treating gynecological malignancies have been achieved. In particular, target therapies, mostly monoclonal antibodies, have emerged as an attractive option for the treatment of these malignancies. In fact, various molecular-targeted agents have been d
- PMID 22235224
- Preclinical studies and clinical utilization of monoclonal antibodies in epithelial ovarian cancer.
- Frederick PJ, Straughn JM Jr, Alvarez RD, Buchsbaum DJ.SourceDivision of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL 35249, USA. pfrederick5@hotmail.com
- Gynecologic oncology.Gynecol Oncol.2009 Jun;113(3):384-90. Epub 2009 Feb 20.
- OBJECTIVE: To present an overview of selected monoclonal antibodies (mAbs) that have been studied in epithelial ovarian cancer with a focus on combination treatment with conventional chemotherapy.METHODS: The authors perform a narrative review of the literature. Preclinical studies that provided rat
- PMID 19232697
Related Pictures
★リンクテーブル★
| リンク元 | 「mab」 |
「mab」
mab
- abciximab
- adahmumab
- adalimumab
- afelimomab
- alemtuzumab
- apolizumab
- arcitumomab
- basiliximab
- bevacizumab
- cantuzumab
- certolizumab
- cetolizumab
- cetuximab
- clenoliximab
- daclizumab
- デノスマブ denosumab 抗RANKL抗体
- eculizumab
- edrecolomab
- efalizumab
- epratuzumab
- galiximab
- gemtuzumab
- ibritumomab
- インフリキシマブ infliximab 抗TNF-α抗体 クローン病 Ph+ALL
- inotuzumab
- keliximab
- natalizumab
- nebacumab
- omalilzumab
- omalizumab
- oregovomab
- palivizumab
- panitumumab
- pertuzumab
- pexelizumab
- リツキシマブ rituximab：抗CD20抗体：慢性リンパ性白血病、B細胞リンパ腫